Oxelumab is a human monoclonal antibody targeting OX40L designed for the treatment of asthma. Oxelumab was developed by Genentech and co-developed by Roche.
References
Wikipedia
Oxelumab
Tags
- Antineoplastic and immunomodulating drug stubs
- Drugs developed by Genentech
- Drugs developed by Hoffmann-La Roche
- Drugs not assigned an ATC code
- Experimental drugs
- Monoclonal antibody stubs